Cala Health

The Cala kIQ System uses TAPS therapy to deliver transcutaneous afferent patterned stimulation, with an individualized approach to counteract tremor.

Essential tremor is a common neurological condition that causes an uncontrollable shaking, often in the hands. It can deeply impact daily life, making everyday activities such as eating, dressing, or enjoying a cup of coffee difficult.

The article discusses what tremors are, the difference between chronic and occasional tremors, and how tremors are treated.

The page advises people who believe they have Parkinson’s disease or essential tremor to seek professional care and says a doctor can help diagnose their condition.

Essential tremor is when an individual experiences involuntary, rhythmic shaking, unlike intention tremor which is more of a slow, zig-zagging motion.

The post discusses potential causes of involuntary finger twitching and finger tremors, and when to see a doctor.

For patients with essential tremor, a wearable, non-invasive treatment option

The page mentions Fast Company's Most Innovative Companies in Medical Devices.

Cala says its products help people with essential tremor return to activities such as gardening and drinking their morning coffee.

Cala began by creating a non-invasive prescription therapy for hand tremor and released Cala kIQ after years of development.

Monday-Friday 8 am – 7 pm Eastern 5 am – 4 pm Pacific

-1163

Cala Health Inc. says its Privacy Policy describes its practices for personal data collected from users of calahealth.com and related websites, including mycala.com.

Cala Health developed a Comprehensive Compliance Program designed to address federal and state laws and industry standards for product marketing and promotion. It states that it complies with the program and California Health & Safety Code section 119400.

Cala kIQ is indicated for temporary relief of hand tremors in the treated hand after stimulation in adults with essential tremor, and for temporary relief of postural and kinetic hand tremor symptoms affecting some daily activities in adults with Parkinson’s disease.

Cala complies with applicable Federal civil rights laws and does not discriminate based on race, color, national origin, age, disability, or sex. Cala does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. Cala:

Cala Health receives $50 million in growth capital from Trinity Capital to scale its wearable neuromodulation therapy for tremor. The article provides no further details about the financing or therapy.

Apr 2026 · MobiHealthNewsNews article

Trinity Capital provides $50 million in growth capital to Cala Health to scale wearable neuromodulation therapy.

Apr 2026 · Trinity CapitalNews article

The FDA clears Cala Health’s Cala kIQ Plus, a next-generation wearable neurostimulation device for hand tremor in people with Parkinson’s disease and essential tremor. The device is cleared for tremor control.

Apr 2026 · Parkinsons News TodayNews article

The FDA clears Cala Health’s Cala kIQ Plus, a next-generation wearable neuromodulation device for action hand tremor in people with essential tremor and Parkinson disease.

Apr 2026 · NeurologyLiveNews article